Use of the cheap and readily available 99m-tc as a radioisotope to perform tumour-specific metabolic diagnosis in patients with cancer.
Extending the capabilities of an innovative needle-free, single use injector to meet full customisation needs, very high volume manufacturing, minimum time to market delays and very high safety levels.
Development of apple cultivars with resistance to diseases and better fruit quality by combining traditional methods of apple breeding with the most recent selection technologies using molecular tools.
Identification of the causative genes for phenotypical differences in prolificacy, through the identification of quantitative trait loci (qtl) that influence reproductive characteristics in pigs, to enable a direct selection of these genes.
Development and industrial-scale application of a patentable procedure for objectively and reliably guaranteeing the hybrid nature of oil palm seeds, using molecular biology techniques.
The goal of this project is to develop enzymatic cleaning products that will: - reduce surface contamination by an in-depth cleaning - remove adherent microorganisms and biofilms these products are mainly designed for industrial cleaning.
Vegf kinoid anti-angiogenesis novel vaccine candidate: the accelerated development as an add-on treatment of colorectal cancer should offer a more cost-effective and convenient administration and dosage when compared to competing treatments.
We aim to develop antigen specific t cells against different muc1 glycoforms by means of differentiating stem cells in an artificial thymus towards dcs and t cells. These dcs will be transduced with ad-muc1 and given to t cells to generate antigen specific t cells that can be cloned.
To develop, at an industrial level, the first production and refining for plant lipases, and to identify different types of vegetal latex for use as raw material in the extraction of enzymes with commercial value.
The project exploits the concept of combining synergistic components and micro-organisms as replacement for antibiotic based growth promoters.